1. Home
  2. RNXT vs FGF Comparison

RNXT vs FGF Comparison

Compare RNXT & FGF Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • RNXT
  • FGF
  • Stock Information
  • Founded
  • RNXT 2012
  • FGF 2012
  • Country
  • RNXT United States
  • FGF United States
  • Employees
  • RNXT N/A
  • FGF N/A
  • Industry
  • RNXT Biotechnology: Pharmaceutical Preparations
  • FGF Property-Casualty Insurers
  • Sector
  • RNXT Health Care
  • FGF Finance
  • Exchange
  • RNXT Nasdaq
  • FGF Nasdaq
  • Market Cap
  • RNXT 30.0M
  • FGF 28.0M
  • IPO Year
  • RNXT 2021
  • FGF N/A
  • Fundamental
  • Price
  • RNXT $1.27
  • FGF $22.01
  • Analyst Decision
  • RNXT Strong Buy
  • FGF
  • Analyst Count
  • RNXT 2
  • FGF 0
  • Target Price
  • RNXT $6.50
  • FGF N/A
  • AVG Volume (30 Days)
  • RNXT 118.6K
  • FGF 35.7K
  • Earning Date
  • RNXT 11-13-2024
  • FGF 11-14-2024
  • Dividend Yield
  • RNXT N/A
  • FGF N/A
  • EPS Growth
  • RNXT N/A
  • FGF N/A
  • EPS
  • RNXT N/A
  • FGF N/A
  • Revenue
  • RNXT N/A
  • FGF $22,351,000.00
  • Revenue This Year
  • RNXT N/A
  • FGF N/A
  • Revenue Next Year
  • RNXT N/A
  • FGF N/A
  • P/E Ratio
  • RNXT N/A
  • FGF N/A
  • Revenue Growth
  • RNXT N/A
  • FGF N/A
  • 52 Week Low
  • RNXT $0.68
  • FGF $14.21
  • 52 Week High
  • RNXT $2.35
  • FGF $40.75
  • Technical
  • Relative Strength Index (RSI)
  • RNXT 52.77
  • FGF 38.52
  • Support Level
  • RNXT $1.21
  • FGF $23.48
  • Resistance Level
  • RNXT $1.55
  • FGF $27.00
  • Average True Range (ATR)
  • RNXT 0.12
  • FGF 3.44
  • MACD
  • RNXT -0.02
  • FGF -1.21
  • Stochastic Oscillator
  • RNXT 32.20
  • FGF 1.32

About RNXT RenovoRx Inc.

RenovoRx Inc is a clinical-stage biopharmaceutical company developing proprietary targeted combination therapies for high unmet medical need with a goal to improve therapeutic outcomes for cancer patients undergoing treatment. RenovoRx's patented Trans-Arterial Micro-Perfusion therapy platform is designed to ensure precise therapeutic delivery to directly target the tumor while potentially minimizing a therapy's toxicities versus systemic intravenous therapy.

About FGF FG Financial Group Inc. (NV)

Fundamental Global Inc through its subsidiaries operates as diversified insurance, reinsurance, and investment management holding company. The company's segment includes Insurance and Asset Management. It generates maximum revenue from the Insurance segment.

Share on Social Networks: